Antibody blockade effective in treatment of severe COVID-19

by | Aug 31, 2020 | Asthma in the News | 0 comments

Researchers find an overlap in the pathogenesis of cytokine release syndrome and COVID-19, and show that the symptoms of both can be alleviated by IL-6 signaling blockade.

Submit a Comment

Your email address will not be published. Required fields are marked *